News brief
On 2026-08-06, according to Xiniu Data, Mishenzhiyuan completed equity financing for an undisclosed amount. Investors were Suzhou Gaolingqirui Medical Jiankang Industrial Investment Partnership (Limited Partnership), Suzhou Xingzexingyongxinxing Medical Industrial Investment Fund Management Partnership (Limited Partnership), Beijing Xiaerba Phase Three Guquan Investment Partnership (Limited Partnership). The company is a biomolecular foundation model developer.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年8月06日，据烯牛数据报道，觅深知源完成股权投资融资，金额未披露。投资方为苏州高瓴祈睿医疗健康产业投资合伙企业（有限合伙），苏州杏泽兴涌新兴医疗产业投资基金管理合伙企业（有限合伙），北京夏尔巴三期股权投资合伙企业（有限合伙）。该公司为生物分子基础模型开发商。